Efficacy and Safety of SH T00660AA in Treatment of Endometriosis
NCT00225199 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 198
Last updated 2010-04-23
Summary
The purpose of this study is to demonstrate safety and efficacy of SH T00660AA compared to placebo in the treatment of endometriosis
Conditions
- Endometriosis
Interventions
- DRUG
-
Visanne (BAY86-5258, SH T00660AA)
orally once daily
- DRUG
-
orally once daily
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Bayer Study Director · Bayer
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-03-31
- Completion
- 2006-09-30
More Related Trials
-
Phase 3 Study of Dienogest for the Treatment of Endometriosis in Chinese Patients
NCT01822080 ·Status: COMPLETED ·Phase: PHASE3
-
Daily Practice Treatment and Influence of Visanne on the Patient Assessment of Quality of Life
NCT01595724 ·Status: COMPLETED
-
A Study to Test Whether Study Drug BAY1128688 Brings Pain Relief to Women With Endometriosis and if so to Get a First Idea Which Dose(s) Work Best
NCT03373422 ·Status: TERMINATED ·Phase: PHASE2
-
Ascending Dose Study to Investigate the Safety, Tolerability and Pharmacokinetics of BAY1128688 After Multiple Oral Administrations in Healthy Women
NCT02434640 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Investigate the Efficacy of a Non-hormonal Drug Against Endometriosis Associated Pelvic Pain
NCT00185341 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Study To Investigate The Effectiveness And Safety Of Tanezumab In Treating Pain Associated With Endometriosis
NCT00784693 ·Status: TERMINATED ·Phase: PHASE2
-
Safety, Tolerability and Efficacy of Vaginal Suppositories for Treatment of the Endometriosis
NCT03481842 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
BGS649 Monotherapy in Moderate to Severe Endometriosis Patients
NCT01190475 ·Status: COMPLETED ·Phase: PHASE2
-
A Safety & Efficacy Study of BGS649 in Women With Refractory Endometriosis
NCT01116440 ·Status: TERMINATED ·Phase: PHASE2
-
Study in Healthy Tubal Ligated Women to Evaluate Pharmacodynamics, Safety and Pharmacokinetics of BAY1002670
NCT01816815 ·Status: COMPLETED ·Phase: PHASE1
-
Endometriosis Trial: Study of NBI-56418 in Endometriosis
NCT00109512 ·Status: COMPLETED ·Phase: PHASE2
-
Study Evaluating the Safety and Efficacy of ERB-041 on Reduction of Symptoms Associated With Endometriosis in Reproductive-Aged Women
NCT00318500 ·Status: COMPLETED ·Phase: PHASE2
-
A Multinational, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Investigate the Efficacy, Safety and Duration of Effect of a Single Administration of Various Doses of Cetrorelix SR in Subjects With Histologically Confirmed Endometriosis
NCT00244452 ·Status: COMPLETED ·Phase: PHASE2
-
The Pharmacokinetic(PK)/Pharmacodynamics(PD) Study of SHR7280 Tablets in Premenopausal Subjects With Endometriosis.
NCT04417972 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Phase 2 Trial to Investigate Efficacy and Safety of Vipoglanstat in Women With Endometriosis
NCT07260669 ·Status: RECRUITING ·Phase: PHASE2
-
A Phase IIa Clinical Study to Assess the Efficacy and Safety of GenSci048 in Patients With Moderate to Severe Endometriosis-Associated Pain
NCT06963177 ·Status: RECRUITING ·Phase: PHASE2
-
Safety and Efficacy Study of MT-2990 in Women With Endometriosis
NCT03840993 ·Status: COMPLETED ·Phase: PHASE2
-
Mifepristone 2.5, 5, 10 mg Versus Placebo in the Treatment of Endometriosis
NCT02271958 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Safety and Efficacy Study to Evaluate Proellex in the Treatment of Premenopausal Women With Symptomatic Endometriosis
NCT00556075 ·Status: TERMINATED ·Phase: PHASE2
-
Letrozole in the Treatment of Severe and Recurrent Endometriosis
NCT00240942 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Learn More About How Safe Dienogest is and How Well it Works Under Real World Conditions in Indian Women With Endometriosis
NCT04808843 ·Status: COMPLETED
-
Regulatory Post Marketing Surveillance Study in Korea
NCT01788722 ·Status: COMPLETED
-
A Study to Investigate Efficacy and Safety of OG-6219 BID in 3 Dose Levels Compared With Placebo in Participants Aged 18 to 49 With Moderate to Severe Endometriosis-related Pain
NCT05560646 ·Status: COMPLETED ·Phase: PHASE2
-
Pituitary Down-regulation Before IVF for Women With Endometriosis
NCT01757249 ·Status: TERMINATED ·Phase: PHASE4
-
Efficacy and Safety of TAK-385 in the Treatment of Endometriosis
NCT01458301 ·Status: COMPLETED ·Phase: PHASE2